Monopoly 2.0 - dealing with dominance in today's digital economy and life-sciences sectors

Stockholm

11 - 13 June 2020


In June 2020 Stockholm will host the AIJA conference titled ‘Monopoly: 2.0, dealing with dominance in today's digital economy and life-sciences sectors'. This joint seminar organised by the AIJA Antitrust Commission in cooperation with the AIJA Healthcare & Life-Sciences Commission will focus on ‘dominance’ and its consequences, rethinking the concept and the definition of market power in a global and digital economy and in markets that are rapidly changing, in particular also addressing the life-sciences sector. 

With great power comes great responsibility. This century old adagium is very much alive in antitrust policy and enforcement. The most recent developments will be tackled, including antitrust enforcers' approach to BigTech across the globe, platform-to-business relationships, the interplay between competition laws and privacy regulation, the rise of eco-systems as well as merger control developments.

The healthcare and life sciences break-out sessions will compare how important issues related to purchases of pharmaceutical products are handled around the world and use this unique opportunity to assess how competition law affects healthcare and life sciences. 

Join us in Stockholm to learn and debate these trending topics! The academic programme will be complemented by a rich social schedule, with a chance to see Stockholm from the seaside and excellent opportunities to meet and see old and new friends.


AIJA Commissions

  • Antitrust
  • Healthcare and Life Sciences

Full programme

Antitrust Track

Thursday 11 June 2020

18:00 » 19:00
Registration at the Clarion Hotel Sign
Address: Östra Järnvägsgatan 35, 111 20 Stockholm, Sweden
19:00 » 20:30
Welcome cocktails at the Clarion Hotel Sign
Address: Östra Järnvägsgatan 35, 111 20 Stockholm, Sweden
21:00 » 23:00
Optional dinner
23:00
Optional bar and clubbing

Friday 12 June 2020

08:00 » 09:00
Registration at the Clarion Hotel Sign
Address: Östra Järnvägsgatan 35, 111 20 Stockholm, Sweden
09:00 » 09:30
Introduction to the Seminar by AIJA President
09:30 » 10:30
Seminar session 1: Monopoly 2.0 - Introduction to the game
Introduction: Academic background and introduction to the main challenges in rapidly evolving markets
Moderator:
Sofia Falkner, Advokatfirman Hammarskiöld (Sweden)
10:30 » 11:00
Coffee break
11:00 » 12:30
Seminar session 2: Rethinking dominance and the concept of abuse
  • Is the current legal framework to take into account new factors when assessing market power/ whether a monopoly exists? Can we still apply traditional methods for the definition of markets that are rapidly changing?
  • What behaviour of a company with a dominant position may constitute an abuse of a dominant position?
Moderator:
Sebastian Janka, Luther Rechtsanwaltsgesellschaft mbH
12:30 » 13:30
Lunch
13:30 » 15:00
Seminar session 3: Life Sciences – Dominance and its abuse (Article 102) in the moment of patent expiration
  • Narrow definition of markets for pharmaceutical products – is every innovative producer a dominant?
  • Pay-for-delay abuse of dominance
  • Market definition and dominance contra innovation and pipeline products
  • Practical aspects of producers of dominant drugs in the moment of patent expiration
Moderator:
Martin Abraham, Abraham & Partneři
15:00 » 15:30
Coffee break
15:30 » 17:00
Seminar session 4.1: Procedure, sanctions and remedies
Moderator:
Johanna Svantesson, DLA Piper
20:00
Dinner
23:00
Optional bar and clubbing

Saturday 13 June 2020

09:30 » 11:00
Seminar session 5.1: Regulating BigTech
  • US investigations
  • EU developments
  • Approach in Asia
Moderator:
Johan Wahlbom, Vinge
11:00 » 11:30
Coffee break
11:30 » 13:00
Seminar session 6.1: Data and platform economy
  • “New” competitive problems regarding platforms as two-sided markets
  • Data protection as a competitive concern for internet “giants”?: investigations into platforms such as Facebook
  • Algorithms and Competition (e.g. study of German FCO and French Autorité de la Concurrence)
  • Network effects 2.0: Mergers of platforms (e.g. Dating & Real Estate)
Responsible contact person:
Beatrice Stange, Heuking Kühn Lüer Wojtek
13:00 » 14:00
Lunch
14:30 » 18:30
Optional afternoon social program
20:30
Optional dinner

Healthcare and Life Sciences Track

Thursday 11 June 2020

18:00 » 19:00
Registration at the Clarion Hotel Sign
Address: Östra Järnvägsgatan 35, 111 20 Stockholm, Sweden
19:00 » 20:30
Welcome cocktails at the Clarion Hotel Sign
Address: Östra Järnvägsgatan 35, 111 20 Stockholm, Sweden
21:00 » 23:00
Optional dinner
23:00
Optional bar and clubbing

Friday 12 June 2020

08:00 » 09:00
Registration at the Clarion Hotel Sign
Address: Östra Järnvägsgatan 35, 111 20 Stockholm, Sweden
09:00 » 09:30
Introduction to the Seminar by AIJA President
09:30 » 10:30
Seminar session 1: Monopoly 2.0 - Introduction to the game
Introduction: Academic background and introduction to the main challenges in rapidly evolving markets
Moderator:
Sofia Falkner, Advokatfirman Hammarskiöld (Sweden)
10:30 » 11:00
Coffee break
11:00 » 12:30
Seminar session 2: Rethinking dominance and the concept of abuse
  • Is the current legal framework to take into account new factors when assessing market power/ whether a monopoly exists? Can we still apply traditional methods for the definition of markets that are rapidly changing?
  • What behaviour of a company with a dominant position may constitute an abuse of a dominant position?
Moderator:
Sebastian Janka, Luther Rechtsanwaltsgesellschaft mbH
12:30 » 13:30
Lunch
13:30 » 15:00
Seminar session 3: Life Sciences – Dominance and its abuse (Article 102) in the moment of patent expiration
  • Narrow definition of markets for pharmaceutical products – is every innovative producer a dominant?
  • Pay-for-delay abuse of dominance
  • Market definition and dominance contra innovation and pipeline products
  • Practical aspects of producers of dominant drugs in the moment of patent expiration
Moderator:
Martin Abraham, Abraham & Partneři
15:30 » 17:00
Seminar session 4.2: Practical implications on the Medical Device Regulation (MDR)
  • Current status – what is in place and what is missing?
  • Update from the authorities
  • The death of small med-tech companies and start-ups?
  • How to mitigate risk in the yet uncertain fields
  • Brexit
Responsible contact person/Moderator:
Siri Mårtensson Hjälmberg, Morris Law
20:00
Dinner
23:00
Optional bar and clubbing

Saturday 13 June 2020

09:30 » 11:00
Seminar session 5.2: Purchasing pharmaceutical products – introductory session
I. Patient’s legal right to free healthcare vs public interest on financial stability of the healthcare system (in the world of new super expensive pharmaceutical products)
a)       Is there a limit on costs per patient, i.e. on his legal right to free healthcare?
b)      Who decides?
c)       Does the patient have a judicial recourse?
d)      Do patients have access to pharmaceutical products without set reimbursement and/or maximal price? Under what circumstances?
II. Interventions of national drugs authorities into prices of pharmaceutical products - are pharmaceutical companies obliged to sell below their market prices, hurting their external pricing reference?
Responsible contact person:
Tímea Halkó, Gedeon Richter Plc.
11:00 » 11:30
Coffee break
11:30 » 13:00
Seminar session 6.2: Purchasing pharmaceutical products – interactive session- mock constitutional trial
Patient in need of super expensive cure suing his public sick-fund
13:00 » 14:00
Lunch
14:30 » 18:00
Optional afternoon social program
20:30
Optional dinner

Sponsors


PLATINUM


Organising Committee

Martin ABRAHAM
Abraham & Partneri, advokatni kancelar s.r.o. (CZECH REPUBLIC)

Sofia FALKNER
Advokatfirman Hammarskiöld & Co AB (SWEDEN)

Sophie GILLIAM
DLA Piper Nederland N.V. (NETHERLANDS)

Tímea HALKO
Gedeon Richter Plc. (HUNGARY)

Siri MåRTENSSON
Advokatfirman Morris AB (SWEDEN)

Boris OSTROUKHOV
ALRUD Law Firm (RUSSIAN FEDERATION)

Beatrice STANGE
Heuking Kühn Lüer Wojtek PartmbB (GERMANY)

Johanna SVANTESSON
Advokatfirma DLA Piper Sweden KB (SWEDEN)

Ewan TOWNSEND
Arnold & Porter (UNITED KINGDOM)

Johan WAHLBOM
Advokatfirman Vinge KB (SWEDEN)